Production (Stage)
Asia Green Biotechnology Corp.
ASIA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 477.36% | 267.26% | 104.72% | 13.89% | -71.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 234.72% | 144.52% | 38.51% | -14.03% | -67.25% |
| Operating Income | -234.72% | -144.52% | -38.51% | 14.03% | 67.25% |
| Income Before Tax | -245.37% | -177.19% | -87.04% | -28.93% | 64.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -245.37% | -177.19% | -87.04% | -28.93% | 64.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -245.37% | -177.19% | -87.04% | -28.93% | 64.94% |
| EBIT | -234.72% | -144.52% | -38.51% | 14.03% | 67.25% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -238.10% | -168.00% | -82.14% | -25.00% | 74.70% |
| Normalized Basic EPS | -275.00% | -200.00% | -93.75% | -28.57% | 76.47% |
| EPS Diluted | -238.10% | -168.00% | -82.14% | -25.00% | 74.70% |
| Normalized Diluted EPS | -275.00% | -200.00% | -93.75% | -28.57% | 76.47% |
| Average Basic Shares Outstanding | -0.39% | -0.26% | -0.06% | 0.33% | 13.79% |
| Average Diluted Shares Outstanding | -0.39% | -0.26% | -0.06% | 0.33% | 13.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |